Back to Search Start Over

Moderna's New COVID-19 Vaccine Elicits Strong Immune Response in Phase 3 Trial

Authors :
Ernst, Diana
Source :
MPR Monthly Prescribing Reference. March 27, 2024
Publication Year :
2024

Abstract

Positive results were observed in a phase 3 trial evaluating Moderna’s next-generation COVID-19 vaccine, mRNA-1283. The phase 3 NextCOVE study (ClinicalTrials.gov Identifier: https://classic.clinicaltrials.gov/ct2/show/NCT05815498) compared the safety, reactogenicity, relative vaccine efficacy [...]

Subjects

Subjects :
RNA -- Health aspects
Clinical trials -- Health aspects
Vaccines -- Product development
Health

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.787872373

Tools

Authors Abstract Subjects Details